Meniscal INfiltration of Corticosteroid Guided With Ultra Sonography
ConditionMeniscus Lesion
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
The value of corticosteroid infiltration of the meniscus wall in the therapeutic strategy is not clearly defined: the data in the literature on the effectiveness of corticosteroid infiltration are heterogeneous and of low level of proof. We hypothesize that corticosteroid infiltration of the meniscal wall under ultrasound control would be effective for rapid relief of degenerative meniscal pain.
The main objective is to evaluate the efficacy of ultrasound-guided meniscal wall infiltration of betamethasone versus ultrasound-guided meniscal wall infiltration of placebo, at 1 month, on meniscal pain in the treatment of meniscal pain of degenerative origin in adult.
Eligibility criteria
Qualifiers
Localized knee pain with tenderness over the medial or lateral joint space reproduced on clinical examination
Pain assessed with a VAS score > 4/10 despite first-line medical treatment including the use of tier I or II analgesics or NSAIDs.
An MRI of the knee performed in the 6 months preceding the operation as part of the pre-treatment assessment
Medial or lateral degenerative meniscal lesion on MRI consistent with pain, confirmed by an investigating physician
Disqualifiers
Patient under curatorship, guardianship or safeguard of justice
Inability to speak, read or write French fluently
Patient deprived of liberty
Patients with psychiatric pathology
Trial design
Treatments tested in this trial
- ultrasound-guided betamethasone infiltration of the meniscal wall
- ultrasound-guided isotonic saline (placebo) infiltration of the meniscal wall
Treatment groups
152 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov